{"id":"https://openalex.org/W2370062022","doi":null,"title":"The effects of simvastatin plus omega-3 fatty acid on HsCRP, blood lipids and fibrinolysis in patients with mixed dyslipidemia","display_name":"The effects of simvastatin plus omega-3 fatty acid on HsCRP, blood lipids and fibrinolysis in patients with mixed dyslipidemia","publication_year":2004,"publication_date":"2004-01-01","ids":{"openalex":"https://openalex.org/W2370062022","mag":"2370062022"},"language":"en","primary_location":{"id":"mag:2370062022","doi":null,"is_oa":false,"landing_page_url":"https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZXYZ200403024.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764576346","display_name":"Chinese New Drugs Journal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Chinese New Drugs Journal","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Hong Lee Heng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Hong Lee Heng","raw_affiliation_strings":[",XU Zhi-min ,WANG Ming-sheng ,PANG Bao-sen, WEI Yu ,GUO Wen-jing, MAO Yan-ling"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":",XU Zhi-min ,WANG Ming-sheng ,PANG Bao-sen, WEI Yu ,GUO Wen-jing, MAO Yan-ling","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.32912962,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9312000274658203,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9312000274658203,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10387","display_name":"Fatty Acid Research and Health","score":0.06759999692440033,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/simvastatin","display_name":"simvastatin","score":1.0},{"id":"https://openalex.org/keywords/omega-3-fatty-acids","display_name":"omega-3 fatty acids","score":0.9990000128746033},{"id":"https://openalex.org/keywords/mixed-dyslipidemia","display_name":"mixed dyslipidemia","score":0.9819999933242798},{"id":"https://openalex.org/keywords/coronary-artery-disease","display_name":"coronary artery disease","score":0.8939999938011169},{"id":"https://openalex.org/keywords/high-sensitivity-c-reactive-protein","display_name":"high-sensitivity C-reactive protein","score":0.9179999828338623},{"id":"https://openalex.org/keywords/serum-lipids","display_name":"serum lipids","score":0.8500000238418579},{"id":"https://openalex.org/keywords/fibrinolysis","display_name":"fibrinolysis","score":0.9729999899864197},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.953000009059906},{"id":"https://openalex.org/keywords/total-cholesterol-hdl-ratio","display_name":"TC/HDL-C ratio","score":0.7680000066757202},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.4050000011920929},{"id":"https://openalex.org/keywords/lipid-lowering-effect","display_name":"hypolipidemic effect","score":0.6769999861717224},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.824999988079071}],"concepts":[{"id":"https://openalex.org/C2776329913","wikidata":"https://www.wikidata.org/wiki/Q670131","display_name":"Simvastatin","level":2,"score":0.9697747230529785},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.8641740083694458},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6921902894973755},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.665590763092041},{"id":"https://openalex.org/C139572402","wikidata":"https://www.wikidata.org/wiki/Q4927820","display_name":"Blood lipids","level":3,"score":0.6079862117767334},{"id":"https://openalex.org/C2776825266","wikidata":"https://www.wikidata.org/wiki/Q1410794","display_name":"Fibrinolysis","level":2,"score":0.6078484654426575},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5083968043327332},{"id":"https://openalex.org/C3017514745","wikidata":"https://www.wikidata.org/wiki/Q191756","display_name":"Omega 3 fatty acid","level":5,"score":0.5069460868835449},{"id":"https://openalex.org/C2781195455","wikidata":"https://www.wikidata.org/wiki/Q422766","display_name":"C-reactive protein","level":3,"score":0.46588626503944397},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4508117437362671},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.43632790446281433},{"id":"https://openalex.org/C543025807","wikidata":"https://www.wikidata.org/wiki/Q61476","display_name":"Fatty acid","level":2,"score":0.42710641026496887},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.33131009340286255},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2615196704864502},{"id":"https://openalex.org/C19038510","wikidata":"https://www.wikidata.org/wiki/Q2005087","display_name":"Polyunsaturated fatty acid","level":3,"score":0.21585911512374878},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18625763058662415},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.13694098591804504},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.08304250240325928},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C2777171753","wikidata":"https://www.wikidata.org/wiki/Q423345","display_name":"Docosahexaenoic acid","level":4,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2370062022","doi":null,"is_oa":false,"landing_page_url":"https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZXYZ200403024.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764576346","display_name":"Chinese New Drugs Journal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Chinese New Drugs Journal","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W148171918","https://openalex.org/W2362829796","https://openalex.org/W2026613797","https://openalex.org/W2149409142","https://openalex.org/W2067335608","https://openalex.org/W2142284567","https://openalex.org/W2408760112","https://openalex.org/W3100212498","https://openalex.org/W2034054895","https://openalex.org/W2124205721"],"abstract_inverted_index":{"Objective:To":[0],"evaluate":[1],"the":[2,42,120,128,140],"effects":[3,160,164],"of":[4,72,115,134,146,165],"simvastatin":[5,55,79,156],"plus":[6],"omega-3":[7,65,150],"fatty":[8,66,151],"acids":[9,67,152],"on":[10],"HsCRP":[11,116,147],"(high":[12],"sensitive":[13],"C-reactive":[14],"protein),":[15],"blood":[16],"lipids":[17],"and":[18,45,85,103,117,127,131,143,161],"fibrinolysis":[19],"in":[20,68,76,119],"patients":[21,26],"with":[22,27,36,51,109],"mixed":[23,37],"dyslipidemia.":[24],"Methods:40":[25],"CHD":[28,33],"(coronary":[29],"heart":[30],"disease)":[31],"or":[32,53,74],"crisis":[34],"complicated":[35],"dyslipidemia":[38],"were":[39,60,87,136],"enrolled":[40],"into":[41],"randomized,":[43],"controlled":[44],"placebo":[46,75],"parallel":[47],"study.":[48],"After":[49],"treated":[50],"10mg":[52],"20mg":[54],"for":[56,80],"6-12":[57],"weeks,":[58],"they":[59],"equally":[61],"divided":[62],"to":[63,78,139,155],"receive":[64],"a":[69],"daily":[70],"dose":[71],"3g":[73],"addition":[77],"2":[81],"months.":[82],"Results:The":[83],"HsCRP,TG,TC":[84],"TC/HDL-C":[86],"significantly":[88],"decreased":[89,129,132,141,144],"by":[90],"38.":[91],"5%":[92],"(":[93],"P0.":[94],"01),":[95],"31.1%":[96],"(P":[97],"0.":[98,104],"001),":[99],"6.":[100],"3%":[101],"(P0.05)":[102,106],"78\u00b11.60":[105],"respectively":[107],"compared":[108],"their":[110],"baseline":[111],"value.":[112],"The":[113],"decrease":[114],"TG":[118,135],"control":[121],"group":[122],"was":[123],"even":[124],"more":[125],"pronounced":[126],"level":[130,142],"percentage":[133,145],"positively":[137],"related":[138],"respectively.":[148],"Conclusion:After":[149],"are":[153,168],"added":[154],"regimen,the":[157],"lipid":[158],"regulating":[159,163],"non-lipid":[162],"both":[166],"drugs":[167],"enhanced.":[169]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}